Pharmacotherapy

Papers
(The median citation count of Pharmacotherapy is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
80
Changes in serum potassium in people with type 2 diabetes taking sodium‐glucose co‐transporter‐2 inhibitors79
Safety and efficacy of cefiderocol for off‐label treatment indications: A systematic review61
Warfarin dosage in a postpartum woman while breastfeeding: A case report46
Association of bleeding with serotonergic antidepressants in patients receiving left ventricular assist device support44
Assessment and management of iatrogenic withdrawal syndrome and delirium in pediatric intensive care units across Europe: An ESPNIC survey41
Hydroxyurea treatment for sickle cell anemia during pregnancy and lactation: Current evidence and knowledge gaps40
Update and narrative review of avian influenza (H5N1) infection in adult patients38
Comparison of risk‐scoring systems for heparin‐induced thrombocytopenia in cardiac surgery patients33
Treatment of patients with serious infections due to carbapenem‐resistant Acinetobacter baumannii: How viable are the current options?32
Acid‐suppressive drugs: A systematic review and network meta‐analysis of their nocturnal acid‐inhibitory effect32
Empiric dosing strategies to predict lamotrigine concentrations during pregnancy31
Characterization of lamotrigine disposition changes during and after pregnancy in women with epilepsy30
29
Role of maternal COVID‐19 vaccination in providing immunological protection to the newborn26
Impact of concurrent gabapentin or pregabalin with high‐dose melphalan in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplant26
Impact of CYP3A5 phenotype on tacrolimus time in therapeutic range and clinical outcomes in pediatric renal and heart transplant recipients25
Reduced risk of NSAID‐Induced adverse events with concomitant use of misoprostol (MICRO study)25
Statin‐associated muscle symptoms—A review: Individualizing the approach to optimize care25
Reversal of apixaban and rivaroxaban with andexanet alfa prior to invasive or surgical procedures24
Evaluation of the safety and tolerability of intravenous undiluted levetiracetam at a pediatric institution23
Optimal starting dosing regimen of intravenous oxytocin for labor induction based on the population kinetic‐pharmacodynamic model of uterine contraction frequency22
Oral fluoroquinolones and risk of aortic aneurysm or dissection: A nationwide population‐based propensity score‐matched cohort study21
Patient safety outcomes for continuous infusion vancomycin as outpatient parenteral antimicrobial therapy21
Determination of vancomycin exposure target and individualized dosing recommendations for critically ill patients undergoing continuous renal replacement therapy21
Biomarkers in the intensive care setting: A focus on using procalcitonin and C‐reactive protein to optimize antimicrobial duration of therapy21
Comment on “Evaluation of the safety and tolerability of intravenous undiluted levetiracetam at a pediatric institution”20
Response to comment on “Dosing implications for liposomal amphotericin B in pregnancy”20
Elbasvir/grazoprevir administered for 12 weeks via percutaneous endoscopic gastrostomy tube achieves sustained virologic response: A case report and a review of the literature20
Consensus recommendations for the use of novel antiretrovirals in persons with HIV who are heavily treatment‐experienced and/or have multidrug‐resistant HIV‐1: Endorse20
20
Issue Information19
Management of diffuse alveolar hemorrhage in the hematopoietic stem cell transplantation population: A systematic review18
Role of the gut microbiome in cardiovascular drug response: The potential for clinical application18
Approaches to Precision‐based Anticoagulation management in the critically Ill18
Issue Information17
Pharmacotherapy research landscape and knowledge gaps of opioids in maternal and pediatric populations16
Early combination therapy with immunoglobulin and steroids is associated with shorter ICU length of stay in Multisystem Inflammatory Syndrome in Children (MIS‐C) associated with 16
Pharmacokinetic and pharmacodynamic evaluation of sulbactam‐durlobactam in a critically ill patient on continuous venovenous hemofiltration infected with carbapenem‐resistant Acinetobacter baumanni16
Cefazolin in the treatment of central nervous system infections: A narrative review and recommendation16
Effect of creatine monohydrate on motor function in children with facioscapulohumeral muscular dystrophy: A multicenter, randomized, double‐blind placebo‐controlled crossover trial16
16
Issue Information15
Issue Information15
15
Adverse Effects of Antidepressant Medications and their Management in Children and Adolescents15
15
Issue Information14
Use of proton pump inhibitors and risk of severe COVID‐19: A case–control study in United States Medicare beneficiaries14
Current therapies and challenges for the treatment of Staphylococcus aureus biofilm‐related infections14
Impact of dexmedetomidine in conjunction with a weaning protocol on post‐surgical opioid use in a neonatal intensive care unit14
Comment on “Intravenous ketamine successfully treats treatment‐resistant catatonia in schizophrenia: A case report”14
Proton pump inhibitor concomitant use to prevent oxaliplatin‐induced peripheral neuropathy: Clinical retrospective cohort study14
Issue Information13
Hydrocortisone versus vasopressin for the management of adult patients with septic shock refractory to norepinephrine: A multicenter retrospective study13
13
Pain management considerations in patients living with both pain syndromes and cardiovascular diseases and disorders13
Issue Information13
A dose‐escalation clinical trial of intranasal ketamine for uncontrolled cancer‐related pain12
12
Efficacy and safety of factor Xa inhibitors in low body weight patients12
Impact of concomitant fluconazole on direct oral anticoagulant bleeding risk12
Open‐source maximum a posteriori‐bayesian dosing AdDS to current therapeutic drug monitoring: Adapting to the era of individualized therapy12
Reply to Comment on: Tacrolimus in the treatment of childhood nephrotic syndrome: Machine learning detects novel biomarkers and predicts efficacy12
Cardiovascular and kidney outcomes of spironolactone or eplerenone in combination with ACEI/ARBs in patients with diabetic kidney disease12
Effects of statin therapy and treatment duration on cardiovascular disease risk in patients with nephrotic syndrome: A nested case–control study11
Scoping review of rational polytherapy in patients with drug‐resistant epilepsy11
Risks of serious adverse events and kidney injury in patients treated with ibandronate: A systematic review and meta‐analysis11
Fluoroquinolones and the risk of aortic aneurysm or dissection: A population‐based propensity score‐matched German cohort study11
Caring for two in the ICU: Pharmacologic management of pregnancy‐related complications11
A pharmacogenetic precision medicine approach to analgesia and sedation optimization in critically ill adults10
Issue Information10
Performance of different body weights in the Cockcroft‐Gault equation in critically ill patients with and without augmented renal clearance: A multicenter cohort10
Standards of practice to advance the quality of health care10
External evaluation of neonatal vancomycin population pharmacokinetic models: Moving from first‐order equations to Bayesian‐guided therapeutic monitoring10
The role of inflammation in the pathogenesis and treatment of arrhythmias10
Critique of “Angiotensin‐converting enzyme inhibitors reduce community‐acquired pneumonia hospitalization and mortality”10
Issue Information10
Current clinical pharmacology issues in pregnancy and pediatrics9
Buprenorphine initiation strategies for opioid use disorder and pain management: A systematic review9
Myocardial infarction associated with erenumab: A case report9
Comment on “The power and pitfalls of underpowered studies”9
Impact of medication intensification on 30‐day hospital readmissions in a geriatric trauma population: A multicenter cohort study9
Correction to “Comparative adherence trajectories of oral disease‐modifying agents in multiple sclerosis”9
Association between household opioid prescriptions and risk for overdose among family members not prescribed opioids9
Update on the clinical applications of SGLTis: Insight to benefits beyond hypoglycemic and cardiorenal protection9
Response to comment on “Intravenous ketamine successfully treats treatment‐resistant catatonia in schizophrenia: A case report”9
Cross‐titration from risperidone to clozapine utilizing clozapine serum concentrations: A case report8
Metformin use is associated with reduced acute kidney injury following coronary artery bypass grafting in patients with type 2 diabetes: An inverse probability of treatment weighting analysis8
Aztreonam–avibactam: The dynamic duo against multidrug‐resistant gram‐negative pathogens8
Temporal shifts in safety and efficacy profile of mycophenolate mofetil 2 g versus 3 g daily early after heart transplantation8
Oral stepdown in Gram‐positive bloodstream infections: A step in the right direction8
Precision‐based approaches to delirium in critical illness: A narrative review8
The efficacy and safety of sodium‐glucose cotransporter‐2 inhibitors in solid organ transplant recipients: A scoping review8
Evaluation of anti‐factor Xa concentrations using a body mass index‐based enoxaparin dosing protocol for venous thromboembolism prophylaxis in trauma patients8
Impact of pre‐lung transplant statin use on the development of primary graft dysfunction8
Pharmacokinetic parameters over time during sepsis and the association of target attainment and outcomes in critically ill children and young adults receiving ceftriaxone8
Effect of proton pump inhibitors versus histamine‐2 receptor antagonists on acute kidney injury in septic patients at high risk for developing stress ulcers8
Serum potassium response to single‐dose sodium zirconium cyclosilicate for the treatment of asymptomatic hyperkalemia in hospitalized patients8
Issue Information7
Use of naldemedine is associated with reduced incidence of hyperactive delirium in cancer patients with opioid‐induced constipation: A nationwide retrospective cohort study in Japan7
Response to comment on “International consensus recommendations for the use of prolonged‐infusion β‐lactams endorsed by the American College of Clinical Pharmacy (ACCP), the British Society7
Vancomycin: An analysis and evaluation of eight population pharmacokinetic models for clinical application in general adult population7
Evaluation of hyponatremia among older adults exposed to selective serotonin reuptake inhibitors and thiazide diuretics7
Assessment of a modified MINDS‐based protocol for management of alcohol withdrawal syndrome on an inpatient medical service7
“Comment on ‘international consensus recommendations for the use of prolonged‐infusion β‐lactams endorsed by the American College of Clinical Pharmacy (ACCP), the British Society for Antimi7
Emerging therapies for eosinophilic esophagitis7
Tacrolimus in the treatment of childhood nephrotic syndrome: Machine learning detects novel biomarkers and predicts efficacy7
Comment on “Tacrolimus in the treatment of childhood nephrotic syndrome: Machine learning detects novel biomarkers and predicts efficacy”7
Steno‐sphere: Navigating the enigmatic world of emerging multidrug‐resistantStenotrophomonas maltophilia7
Correction of posaconazole concentrations for hypoalbuminemia6
Clinical outcomes associated with anti‐Xa‐monitored enoxaparin for venous thromboembolism prophylaxis6
6
The effect of antipsychotic treatment on hormonal, inflammatory, and metabolic biomarkers in healthy volunteers: A systematic review and meta‐analysis6
Prevalence of prescription medication use that can exacerbate heart failure among US adults with heart failure6
Retrospective cohort study of oral switch versus intravenous antibiotics for carbapenem‐resistant enterobacterales and Pseudomonas aeruginosa infections on hospital discharge6
6
6
6
TheMPRINTHub Data, Model, Knowledge and Research Coordination Center: Bridging the gap in maternal–pediatric therapeutics research through data integration and pharmacometrics6
Pharmacokinetics/pharmacodynamics analysis and establishment of optimal dosing regimens using unbound cefmetazole concentration for patients infected with Extended‐Spectrum β‐lactamase prod6
Comparison of catheter‐related bloodstream infection rates in pediatric patients receiving parenteral nutrition with soybean oil‐based intravenous fat emulsion versus a mixed oil fat emulsion6
Beneficial and harmful outcomes of tocilizumab in severe COVID‐19: A systematic review and meta‐analysis6
Issue Information6
6
Effect of cilostazol on preventing paclitaxel‐induced neuropathy in patients with breast cancer: A randomized controlled trial6
6
Population pharmacokinetics of linezolid and its major metabolites PNU‐142300 and PNU‐142586 in adult patients6
Cardiovascular adverse events in patients with hepatocellular carcinoma receiving vascular endothelial growth factor inhibitors6
Transfer of antibiotics and their metabolites in human milk: Implications for infant health and microbiota6
Expert consensus recommendations for innovative antiretroviral drugs6
Issue Information6
ERRATUM5
5
Comment on “Dosing implications for liposomal amphotericin B in pregnancy”5
Risk of parkinsonism and related movement disorders with gabapentinoids or tramadol: A case‐crossover study5
Examining the clinical impact of rapid multiplex polymerase chain reaction‐based diagnostic testing for bloodstream infections in a national cohort of the Veterans Health Administration5
Impacts of age and BMI on vancomycin model choice in a Bayesian software: Lessons from a very large multi‐site retrospective study5
Efficacy of adjuvant use of midodrine in patients with septic shock: An open label randomized controlled trial5
Early clinical trial data and real‐world assessment of COVID‐19 vaccines: Insights from the Society of Infectious Diseases Pharmacists5
PROK2, HRNR, and FIG4 as potential genetic biomarkers of high bleeding propensity in East Asian patients with acute coronary syndrome using ticagrelor5
ECLIPSES: Early initiation of sodium glucose cotransporter‐2 inhibitors for cardiovascular protection in patients with type 2 diabetes following acute coronary syndrom5
Issue Information5
A pragmatic assessment of proton pump inhibitors vs. histamine type 2 receptor antagonists on clinically important gastrointestinal bleeding and mortality when used for stress ulcer prophylaxis in the5
Comparison of Bayesian‐derived and first‐order analytic equations for calculation of vancomycin area under the curve5
Simulated cost‐effectiveness of a novel precision‐guided dosing strategy in adult patients with Crohn's disease initiating infliximab maintenance therapy5
5
Hospitalizations for opioid‐related overdose and timing of concurrent opioid and benzodiazepine use: A nested case‐control study5
Treatment of persistent methicillin‐susceptible Staphylococcus aureus bacteremia and presumed osteomyelitis with oxacillin and ertapenem in a premature neonate5
Chloride dipstick to rapidly estimate urine sodium during diuresis in acute heart failure5
Response to intravenous racemic ketamine after switch from intranasal (S)‐ketamine on symptoms of treatment‐resistant depression and post‐traumatic stress disorder in Veterans: A retrospective case se5
Increasing the bioavailability of oral esketamine by a single dose of cobicistat: A case study5
Issue Information4
Safety and effectiveness of NMDA receptor antagonists for depression: A multidisciplinary review4
Precision medicine in the ICU: One size fits one patient4
Contribution of pharmaceutical drugs of dependence to the incidence of neonatal abstinence syndrome in Western Australia between 2003 and 20184
The gray area of scientific adequacy4
Glucagon: Its evolving role in the management of hypoglycemia4
GLP‐1RA‐induced delays in gastrointestinal motility: Predicted effects on coadministered drug absorption by PBPK analysis4
Association between mineralocorticoid receptor antagonists and kidney harm: A systematic review and meta‐analysis of randomized controlled trials4
Poor tolerability of cystic fibrosis transmembrane conductance regulator modulator therapy in lung transplant recipients4
Effectiveness of sacubitril/valsartan versus aldosterone antagonists in heart failure with reduced ejection fraction: A retrospective cohort study4
Thirty‐day risk of digoxin toxicity among older adults co‐prescribed trimethoprim‐sulfamethoxazole versus amoxicillin: A population‐based cohort study4
Trends in the appropriateness of oral antibiotic prescriptions dispensed in the United States from 2010 to 20184
Association of atrial fibrillation with lamotrigine: An observational cohort study4
Transplacental methadone exposure and risk of Neonatal Opioid Withdrawal Syndrome4
Delirium event and associated treatment modifications among older adults with Alzheimer's disease: An interrupted time‐series analysis of Medicare data4
Accelerated approval drug labels often lack information for clinical decision‐making4
International consensus recommendations for the use of prolonged‐infusion beta‐lactam antibiotics: Endorsed by the American College of Clinical Pharmacy, British Society for Antimicrobial Chemotherapy4
Precision fluid and vasoactive drug therapy for critically ill patients4
Personalizing prevention: Advances in pharmacotherapy for HIV prevention4
Issue Information4
Multicenter study evaluating target attainment of anti‐Factor Xa levels using various enoxaparin prophylactic dosing practices in adult trauma patients3
Prescribing cascades in ambulatory care: A structured synthesis of evidence3
Characterization of antiplatelet response to low‐dose cangrelor utilizing platelet function testing in neuroendovascular patients3
Randomized controlled trial to compare safety and efficacy of mycophenolate vs. cyclosporine after rituximab in children with steroid‐resistant nephrotic syndrome3
Efficacy and safety of mirikizumab compared with currently approved biologic drugs for the treatment of ulcerative colitis: A systematic review and network meta‐analysis3
Issue Information3
3
3
Comparative effectiveness of sodium‐glucose cotransporter‐2 inhibitors among patients with heart failure with preserved ejection fraction3
Pharmacogenomics and beyond! Customized pharmacotherapy for solid organ transplant recipients3
Correction to “International consensus recommendations for the use of prolonged‐infusion beta‐lactam antibiotics: Endorsed by the American College of Clinical Pharmacy, British Society for Antimicrobi3
3
Phase I study of the pharmacokinetics and safety of rezafungin in subjects with moderate/severe hepatic impairment and matched control subjects3
Issue Information3
Path of least recurrence: A systematic review and meta‐analysis of fidaxomicin versus vancomycin for Clostridioides difficile infection3
Effects of aging on clinical outcomes in patients receiving genotype‐guided P2Y12 inhibitor selection after percutaneous coronary intervention3
Correction to “Risk of incident antidepressant‐treated depression associated with use of 5α‐reductase inhibitors compared with use of α‐blockers in men with benign prostatic hyperplasia: A population‐3
Belzutifan's role in the treatment landscape of clear cell renal cell carcinoma3
3
From bottle to bedside: Implementation considerations and antimicrobial stewardship considerations for bloodstream infection rapid diagnostic testing3
Comparative adherence trajectories of oral disease‐modifying agents in multiple sclerosis3
A propensity score‐matching analysis of angiotensin‐converting enzyme inhibitor and angiotensin receptor blocker exposure on in‐hospital mortality in patients with acute respiratory failure3
3
Consensus recommendations for use of long‐acting antiretroviral medications in the treatment and prevention of HIV‐1: Endorsed by the American Academy of HIV Medicine, American College of C3
Disease‐modifying therapies for amyloid transthyretin cardiomyopathy: Current and emerging medications3
Developing precision‐based multidisciplinary pharmacotherapy management plans in the critically ill3
A systematic review of opioid use and multimodal strategies in solid organ transplant recipients and living donors3
Scoping review of augmented renal clearance in critically ill pediatric patients3
A retrospective analysis of bleeding risk with rivaroxaban, enoxaparin, and aspirin following total joint arthroplasty or revision3
Reflections on the future of biomedical publishing3
Issue Information3
3
Response to comment on “Association of atrial fibrillation with lamotrigine: An observational cohort study”3
3
Outcomes of adult patients in the intensive care unit with Pseudomonasaeruginosa pneumonia who received an active anti‐pseudomonal β‐lactam: Does “S” equal success in the presence of res3
Issue Information3
Evaluating the evidence for sacubitril/valsartan across the continuum of heart failure2
Analysis of the frequency distribution of five single‐nucleotide polymorphisms of the MTRRgene in a Chinese pediatric population with acute lymphoblastic leukemia2
Personalized antiseizure medication therapy in critically ill adult patients2
Direct oral to parenteral anticoagulant transitions: Role of factor Xa inhibitor‐specific anti‐Xa concentrations2
Response to comment on “Hydrocortisone versus vasopressin for the management of adult patients with septic shock refractory to norepinephrine: A multicenter retrospective study”2
Issue Information2
Comparing newborn outcomes after prenatal exposure to individual antidepressants: A retrospective cohort study2
Intravenous thrombolysis for patients with acute ischemic stroke while receiving a direct oral anticoagulant: A systematic review and meta‐analysis2
Intravenous ketamine successfully treats treatment‐resistant catatonia in schizophrenia: A case report2
Theophylline for the management of respiratory disorders in adults in the 21st century: A scoping review from the American College of Clinical Pharmacy Pulmonary Practice and Research Network2
Associations between antidepressant use patterns during pregnancy and birth outcomes among periconception antidepressant users2
Anticoagulation strategies in patients with extracorporeal membrane oxygenation: A network meta‐analysis and systematic review2
Switching from intravenous vancomycin to oral antibiotics reduces adverse events in a retrospective cohort of outpatients with orthopedic infections2
Risk of acute kidney injury in dapagliflozin users with type 2 diabetes: A nationwide propensity score‐matched cohort study in Korea2
2
Safety and efficacy of a platelet glycoprotein Ib inhibitor for patients with non‐ST segment elevation myocardial infarction: A phase Ib/IIa study2
Systematic review of drug–drug interactions between rifamycins and anticoagulant and antiplatelet agents and considerations for management2
Vancomycin plus ceftaroline for persistent methicillin‐resistant Staphylococcus aureus bacteremia2
Comment on “Delirium event and associated treatment modifications among older adults with Alzheimer's disease: An interrupted time‐series analysis of Medicare data”2
Development and validation of a model to predict acute kidney injury following high‐dose methotrexate in patients with lymphoma2
Maternal and neonatal outcomes associated with treating hypertension in pregnancy at different thresholds2
Using population pharmacokinetics to optimize initial vancomycin dosing guidelines for neonates to treat sepsis caused by coagulase‐negative staphylococcus2
Potential drug–drug interactions among U.S. adults treated with nirmatrelvir/ritonavir: A cross‐sectional study of the National Covid Cohort Collaborative (N3C)2
Correlation between partial thromboplastin time and thromboelastography in adult critically ill patients requiring bivalirudin for extracorporeal membrane oxygenation2
Updates in pulmonary drug‐resistant tuberculosis pharmacotherapy: A focus on BPaL and BPaLM2
Amoxicillin and penicillin G dosing in pediatric community‐acquired pneumococcal pneumonia in the era of conjugate pneumococcal vaccines2
Impact of timing and dosing of four‐factor prothrombin complex concentrate administration on outcomes in warfarin‐associated intracranial hemorrhage2
Evaluation of dosing strategies and trough concentrations of vancomycin in patients undergoing continuous venovenous hemofiltration2
Impact of the United Network for Organ Sharing policy change on induction immunosuppression practice patterns and outcomes in adult heart transplant recipients2
Anticoagulant drug–drug interactions with cannabinoids: A systematic review2
Insulin requirements after switching from GLP‐1 receptor agonist to dual GIP/GLP‐1 receptor agonist in patients with type 2 diabetes mellitus2
Omega‐3 fatty acids for the prevention of atherosclerotic cardiovascular disease2
Neurodevelopmental outcomes in children prenatally exposed to opioid maintenance treatment: A population‐based study2
Issue Information2
Review of novel β‐lactams and β‐lactam/β‐lactamase inhibitor combinations with implications for pediatric use2
Enhancing thromboprophylaxis after colorectal cancer surgery in China: Bridging the gap between evidence and implementation through pathway optimization2
Renin‐angiotensin‐aldosterone system inhibitors and major cardiovascular events and acute kidney injury in patients with coronary artery disease2
Patient selection for mineralocorticoid receptor antagonists in heart failure with mildly reduced or preserved ejection fraction2
1
Issue Information1
Evaluation of methotrexate Pharmacogenomic variation to predict acute neurotoxicity in children with acute lymphoblastic leukemia1
Genetic polymorphisms and major bleeding risk during vitamin K antagonists treatment: The BLEEDS case‐cohort1
0.068653106689453